SPRY4 and intrahepatic cholangiocarcinoma: Therefore, we hypothesized that loss of SPRY4 could cause increased phosphorylation of ERK upon KIT RTK activation, leading to hyperplasia of the ICC in antrum, and possibly in other parts of the gut.